- Home
- QNCX vs EBMT Comparison
QNCX vs EBMT Comparison
Compare QNCX & EBMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- EBMT
- Stock Information
- Founded
- QNCX 2012
- EBMT 1922
- Country
- QNCX United States
- EBMT United States
- Employees
- QNCX 36
- EBMT N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- EBMT Major Banks
- Sector
- QNCX Health Care
- EBMT Finance
- Exchange
- QNCX Nasdaq
- EBMT Nasdaq
- Market Cap
- QNCX 139.2M
- EBMT 134.3M
- IPO Year
- QNCX 2019
- EBMT N/A
- Fundamental
- Price
- QNCX $2.68
- EBMT $16.60
- Analyst Decision
- QNCX Strong Buy
- EBMT
- Analyst Count
- QNCX 4
- EBMT 0
- Target Price
- QNCX $7.75
- EBMT N/A
- AVG Volume (30 Days)
- QNCX 551.1K
- EBMT 20.3K
- Earning Date
- QNCX 11-12-2025
- EBMT 10-28-2025
- Dividend Yield
- QNCX N/A
- EBMT 3.53%
- EPS Growth
- QNCX N/A
- EBMT 58.15
- EPS
- QNCX N/A
- EBMT 1.72
- Revenue
- QNCX N/A
- EBMT $87,531,000.00
- Revenue This Year
- QNCX N/A
- EBMT N/A
- Revenue Next Year
- QNCX N/A
- EBMT $6.26
- P/E Ratio
- QNCX N/A
- EBMT $9.56
- Revenue Growth
- QNCX N/A
- EBMT 9.36
- 52 Week Low
- QNCX $0.72
- EBMT $14.35
- 52 Week High
- QNCX $2.85
- EBMT $18.49
- Technical
- Relative Strength Index (RSI)
- QNCX 83.72
- EBMT 53.81
- Support Level
- QNCX $1.61
- EBMT $16.05
- Resistance Level
- QNCX $1.84
- EBMT $16.50
- Average True Range (ATR)
- QNCX 0.21
- EBMT 0.32
- MACD
- QNCX 0.10
- EBMT 0.03
- Stochastic Oscillator
- QNCX 87.94
- EBMT 88.89
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About EBMT Eagle Bancorp Montana Inc.
Eagle Bancorp Montana Inc operates as a bank holding company. It provides loan and deposit services. The company focuses on residential loans, commercial real estate loans, commercial loans, consumer loans, and home equity loan products. The bank also offers deposit accounts which include checking, savings, money market, individual retirement accounts, and certificates of deposit accounts. It is a diversified lender with a focus on residential mortgage loans, commercial real estate mortgage loans, commercial business loans, agricultural loans, and second mortgage/home equity loan products.